Agendia, AstraZeneca, NKI Partner to ID Colorectal Cancer Subtypes

The partners will seek to identify specific colorectal cancer subtypes in order to develop targeted therapies.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.